Myopathy associated with neuromyelitis optica spectrum disorders

International Journal of Neuroscience

Volumn 126, Issue 10, 2016, Pages 863-866

  He, Dian ^a   Li, Ya ^a   Dai, Qingqing ^a   Zhang, Yifan ^a   Xu, Zhu ^a   Li, Yuan ^a   Cai, Gang ^a   Chu, Lan ^a  

^a GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

AQP4 IgG; hyperCKemia; longitudinally extensive transverse myelitis; myopathy; neuromyelitis optica spectrum disorders; optic neuritis

Indexed keywords

AQUAPORIN 4; AZATHIOPRINE; CORTICOSTEROID; CREATINE KINASE; METHYLPREDNISOLONE; RITUXIMAB;

CLINICAL FEATURE; COMPLEMENT DEPENDENT CYTOTOXICITY; DISEASE ASSOCIATION; FATIGUE; HUMAN; IMMUNOREACTIVITY; LIMB PAIN; LIMB WEAKNESS; MEDLINE; MUSCLE BIOPSY; MYALGIA; MYELOOPTIC NEUROPATHY; MYOPATHY; NEUROSCIENCE; PATHOGENESIS; PLASMAPHERESIS; REVIEW; SYSTEMATIC REVIEW; COMPLICATION; ENZYMOLOGY; MUSCULAR DISEASES; PATHOPHYSIOLOGY;

HUMANS; MUSCULAR DISEASES; NEUROMYELITIS OPTICA;

EID: 84947784970     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2015.1113175     Document Type: Review

References (23)

1. D.M.Wingerchuk, V.A.Lennon, C.F.Lucchinetti, The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805–15.
2. C.F.Lucchinetti, Y.Guo, B.F.Popescu, The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol 2014;24:83–97.
3. D.M.Wingerchuk, B.Banwell, J.L.Bennett, International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177–89.
4. A.S.Verkman Aquaporins in clinical medicine. Annu Rev Med 2012;63:303–16.
5. D.M.Wingerchuk, V.A.Lennon, S.J.Pittock, Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485–9.
6. A.Iyer, D.Rathnasabapathi, L.Elsone, Transverse myelitis associated with an itchy rash and hyperckemia: neuromyelitis optica associated with dermatitis herpetiformis. JAMA Neurol 2014;71:630–3.
7. N.Yokoyama, M.Niino, T.Takahashi, Seroconversion of neuromyelitis optica spectrum disorder with hyperCKemia: a case report. Eur J Neurol 2012;19:e143.
8. S.Deguchi, K.Deguchi, K.Sato, HyperCKemia related to the initial and recurrent attacks of neuromyelitis optica. Intern Med 2012;51:2617–20.
9. N.Suzuki, T.Takahashi, M.Aoki, Neuromyelitis optica preceded by hyperCKemia episode. Neurology 2010;74:1543–5.
10. J.Cosgrove, S.Alli, H.Ramadan, H.L.Ford. Myocarditis and diffuse skeletal muscle oedema: new features of neuromyelitis optica spectrum disorder? A case report. Mult Scler 2014;20:120–2.
11. M.Di Filippo, D.Franciotta, R.Massa, Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica. Neurology 2012;79:1182–4.
12. H.Okada, M.Wada, H.Sato, Neuromyelitis optica preceded by hyperCKemia and a possible association with coxsackie virus group A10 infection. Intern Med 2013;52:2665–8.
13. R.Malik, A.Lewis, B.A.Cree, Transient hyperckemia in the setting of neuromyelitis optica (NMO). Muscle Nerve 2014;50:859–62.
14. Y.Guo, V.A.Lennon, B.F.Popescu, Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum. JAMA Neurol 2014;71:1025–9.
15. A.Frigeri, G.P.Nicchia, J.M.Verbavatz, Expression of aquaporin-4 in fast-twitch fibers of mammalian skeletal muscle. J Clin Invest 1998;102:695–703.
16. J.D.Ho, R.Yeh, A.Sandstrom, Crystal structure of human aquaporin 4 at 1.8 A and its mechanism of conductance. Proc Natl Acad Sci USA 2009;106:7437–42.
17. M.C.Papadopoulous, A.S.Verkman. Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012;11:535–44.
18. J.M.Crane, C.Lam, A.Rossi, Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays. J Biol Chem 2011;286:16516–24.
19. P.W.Phuan, J.Ratelade, A.Rossi, Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 assembly in orthogonal arrays. J Biol Chem 2012;287:13829–39.
20. C.G.Au, T.L.Butler, J.R.Egan, Changes in skeletal muscle expression of AQP1 and AQP4 in dystrophinopathy and dysferlinopathy patients. Acta Neuropathol 2008;116:235–46.
21. Y.Wakayama, T.Jimi, M.Inoue, Reduced aquaporin 4 expression in the muscle plasma membrane of patients with Duchenne muscular dystrophy. Arch Neurol 2002;59:431–37.
22. S.Saadoun, M.C.Papadopoulos. Role of membrane complement regulators in neuromyelitis optica. Mult Scler. 2015;21:1644–54.
23. A.Zekeridou, V.A.Lennon. Aquaporin-4 autoimmunity. Neurol Neuroimmunol Neuroinflamm. 2015;2:e110.